Evidence map›Paper›PMID 37881193›Full record

ArticleClinical case reports2023

Expression assay of the

Mohammad Farid Mohammadi, Sahand Tehrani Fateh, Hadi Aghajani, Afshin Bahramy, Seyed Mohammad Salar Zaheryani, Javad Behroozi, Seyyed Mohammad Kahani, Pouria Mohammadi, Masoud Garshasbi

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Expression assay of theClinical case reports · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Mohammad Farid MohammadiDepartment of Cell and Molecular Sciences, Faculty of Biological Sciences Kharazmi University Tehran Iran.ORCID https://orcid.org/0000-0003-4966-6658
Sahand Tehrani FatehSchool of Medicine Tehran University of Medical Sciences Tehran Iran.ORCID https://orcid.org/0009-0002-8903-2713
Hadi AghajaniFaculty of Medicine, Tehran Medical Sciences Branch Islamic Azad University Tehran Iran.
Afshin BahramyDepartment of Medical Genetics, Faculty of Medical Sciences Tarbiat Modares University Tehran Iran.ORCID https://orcid.org/0000-0002-3165-1178
Seyed Mohammad Salar ZaheryaniJwan Private Clinic Boukan Iran.
Javad BehrooziDepartment of Medical Genetics, Faculty of Medical Sciences Tarbiat Modares University Tehran Iran.ORCID https://orcid.org/0000-0001-6429-0295
Seyyed Mohammad KahaniDepartment of Medical Genetics, Faculty of Medical Sciences Tarbiat Modares University Tehran Iran.
Pouria MohammadiDepartment of Medical Genetics, Faculty of Medical Sciences Tarbiat Modares University Tehran Iran.ORCID https://orcid.org/0000-0002-7753-0910
Masoud GarshasbiDepartment of Medical Genetics, Faculty of Medical Sciences Tarbiat Modares University Tehran Iran.ORCID https://orcid.org/0000-0002-5508-7903
Tarbiat Modares University · IRIslamic Azad University, Boukan · IRIslamic Azad University Medical Branch of Tehran · IRKharazmi University · IRTehran University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Congenital myasthenic syndromes-5 (CMS5) is a rare autosomal recessive heterogeneous disorder, caused by pathogenic variants in the

Indexed as

COLQcongenital myasthenic syndromeqRT‐PCRsymptomatic carrierswhole‐exome sequencing

Identifiers

PMID37881193
PMCPMC10593973
OpenAlexW4387895804

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.